03:06

Potential of BTK Inhibitors for Primary Progressive Multiple Sclerosis

07:59

Categorizing Biomarker Criteria for Alzheimer Disease Diagnosis and Staging

09:54

Early Biomarker Evaluation and Cognitive Stabilization in Alzheimer Treatment

06:43

Implications of Newly Revised Alzheimer Disease Diagnostic and Staging Criteria

10:28

Exploring Menopause's Impact on Women's Brain Health

04:46

Chronic Pain Treatment Options for an Aging Population in Neurology

05:46

A Time to Recognize and Enhance Understanding of Migraine Disorders

06:51

Advances in Multifaceted Drug Approaches for Dementia in Movement Disorders

10:28

Exploring Menopause's Impact on Women's Brain Health

19:46

Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease

04:38

Integrating Advanced Therapies and Holistic Management in Multiple Sclerosis Care

05:25

Building a Vibrant Community of Neurology Educators

11:24

FDA Approves Donanemab for Early Symptomatic Alzheimer Disease

04:31

Assessing Long Term Benefit of Eptinezumab for Chronic Migraine

04:49

Advanced Therapeutic Options for Parkinson Disease and Essential Tremor

04:56

Enhancing Hospital Care for Patients With Parkinson Disease

03:46

Advancements in Multidisciplinary Parkinson Disease Treatment

06:12

Innovative Wearables to Tackle Bladder Dysfunction in Multiple Sclerosis

03:12

Analyzing Long Term, End Of Study Results for Inebilizumab Treatment in NMOSD

05:46

A Time to Recognize and Enhance Understanding of Migraine Disorders

07:21

Localization and Puzzling Together the Bigger Picture in Multiple Sclerosis

12:27

Breakthroughs in Alzheimer Research Pave Way for New Era of Treatment

05:40

Promising Developments in Pharmaceutical Treatments for Sleep Apnea

04:41

Challenges and Potential of BTK Inhibitors in MS Treatment

03:46

Recognizing the Clinical Features of MOGAD for Diagnosis

04:14

The Importance of Early Referral and Interdisciplinary Care in MS

06:34

Understanding Silent Progression in Multiple Sclerosis

06:11

The Complexity of Immune Cell Interactions and Potential Treatments for MS

05:19

The Challenge of Treating Fatigue in Multiple Sclerosis

05:25

Innovative Therapies to Address Unmet Needs in Acute Ischemic Stroke

04:15

Balancing Efficacy, Safety, and Cost When Deciding Treatment Options for NMOSD

05:26

Consensus Guidelines for Spasticity Assessment and Management

03:23

Overlooked Neurological Features Present in Long COVID

05:20

Regulatory Pathways and Clinical Trials for Gene Therapy in Parkinson Disease

04:25

Efficacy of Switching From to Inebilizumab in Rituximab in NMOSD

05:13

Understanding the Impact of Data Analysis on Preventive Migraine Treatment

04:19

Recent Progress in Advancing Gene Therapy for Parkinson Disease

04:03

A Call to Action to Address Disparities in Multiple Sclerosis Care

04:25

Leveraging Artificial Intelligence to Redefine Clinical Efficacy and Empower Neurologists

07:48

Latest Findings on AXS-05 Treatment for Agitation in Alzheimer Disease

06:24

Using a Blood Collection Device to Advance Genetic Research in Parkinson Disease

03:57

Examining Promising Phase 2b PARADIGM Findings of ALS Agent PrimeC

05:53

Promise of Neuroprotection in Neurodegenerative Diseases Through HGF Compounds

04:51

Potential of Nasal Foralumab in Treating Non-Active Secondary Progressive MS

04:12

A Promising New Approach To Reduce Repeat Surgeries for Subdural Hematomas

02:10

Using New Models to Explore the Origins of Parkinson Disease

05:05

Takotsubo Syndrome and the Brain Heart Connection

01:13

Cenobamate's Efficacy in Drug-Resistant Epilepsy

06:11

Advancing MS Care for Minority Populations Using the VISIBL MS Bilingual Framework

07:40

A Holistic Approach to Preserving Brain Health

00:54

Bobcat mRNA Therapeutic for Duchenne Muscular Dystrophy

04:29

Givinostat's Multifactorial Mechanism of Action in Duchenne Muscular Dystrophy

01:18

Remyelination and Neurodegeneration in Multiple Sclerosis

05:19

NLRX1 in Immune Regulation and Neuroprotection for Inflammatory Neurodegenerative Disorders

05:14

Analyzing Cognitive Profiles in Multiple Sclerosis and Alzheimer Disease

01:48

Justin Moy

04:54

Integrating Genetics and Transitional Support in Muscular Dystrophy Care

00:54

mRNA Therapeutics for Duchenne Muscular Dystrophy

06:10

Challenges in Transitioning Care for Duchenne Muscular Dystrophy

02:41

Consistent Real World Efficacy of Ofatumumab Therapy for Multiple Sclerosis